美股
Lead report
IDEAYA Biosciences Prices $300M Public Offering at $27/Share, Precision Oncology Funding Moves
IDEAYA Biosciences announces a $300 million public offering priced at $27 per share, including common stock and pre-funded warrants. Proceeds will advance precision oncology drug development. Details on the offering, market reaction, and investment implications.
